194 related articles for article (PubMed ID: 32904490)
1. Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.
Li S; Yu C; Zhang Y; Liu J; Jia Y; Sun F; Zhang P; Li J; Guo L; Xiao H; Gao F; Deng X; Cai Z; Cai J
Biomed Res Int; 2020; 2020():7586521. PubMed ID: 32904490
[TBL] [Abstract][Full Text] [Related]
2. Cir-ITCH inhibits gastric cancer migration, invasion and proliferation by regulating the Wnt/β-catenin pathway.
Peng Y; Wang HH
Sci Rep; 2020 Oct; 10(1):17443. PubMed ID: 33060778
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA
Li H; Lan M; Liao X; Tang Z; Yang C
Technol Cancer Res Treat; 2020; 19():1533033819898728. PubMed ID: 31960764
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Rajan P; Sudbery IM; Villasevil ME; Mui E; Fleming J; Davis M; Ahmad I; Edwards J; Sansom OJ; Sims D; Ponting CP; Heger A; McMenemin RM; Pedley ID; Leung HY
Eur Urol; 2014 Jul; 66(1):32-9. PubMed ID: 24054872
[TBL] [Abstract][Full Text] [Related]
5. cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-catenin pathway.
Huang G; Zhu H; Shi Y; Wu W; Cai H; Chen X
PLoS One; 2015; 10(6):e0131225. PubMed ID: 26110611
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway.
Wan L; Zhang L; Fan K; Cheng ZX; Sun QC; Wang JJ
Biomed Res Int; 2016; 2016():1579490. PubMed ID: 27642589
[TBL] [Abstract][Full Text] [Related]
7. CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183.
Jin C; Zhao W; Zhang Z; Liu W
Life Sci; 2020 Jan; 241():117097. PubMed ID: 31760099
[TBL] [Abstract][Full Text] [Related]
8. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
Yang B; Zhao J; Huo T; Zhang M; Wu X
J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway.
Li F; Zhang L; Li W; Deng J; Zheng J; An M; Lu J; Zhou Y
Oncotarget; 2015 Mar; 6(8):6001-13. PubMed ID: 25749389
[TBL] [Abstract][Full Text] [Related]
10. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
[TBL] [Abstract][Full Text] [Related]
12. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
13. Identification of the tumor-suppressive function of circular RNA ITCH in glioma cells through sponging miR-214 and promoting linear ITCH expression.
Li F; Ma K; Sun M; Shi S
Am J Transl Res; 2018; 10(5):1373-1386. PubMed ID: 29887952
[TBL] [Abstract][Full Text] [Related]
14. Role of protein S in castration-resistant prostate cancer-like cells.
Ning P; Zhong JG; Jiang F; Zhang Y; Zhao J; Tian F; Li W
Endocr Relat Cancer; 2016 Aug; 23(8):595-607. PubMed ID: 27342144
[TBL] [Abstract][Full Text] [Related]
15. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
17. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
18. Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Physiol; 2020 Mar; 235(3):2129-2138. PubMed ID: 31468537
[TBL] [Abstract][Full Text] [Related]
19. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
20. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
